Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.56M Sell
13,236
-4,947
-27% -$612K 0.07% 177
2025
Q4
$2.29M Sell
18,183
-4,351
-19% -$568K 0.1% 147
2025
Q3
$3.3M Sell
22,534
-470
-2% -$71K 0.15% 117
2025
Q2
$3.59M Sell
23,004
-1,975
-8% -$313K 0.18% 102
2025
Q1
$4.11M Buy
24,979
+274
+1% +$45.6K 0.23% 86
2024
Q4
$4.03M Sell
24,705
-488
-2% -$87.3K 0.22% 89
2024
Q3
$4.92M Sell
25,193
-44
-0.2% -$8.11K 0.32% 72
2024
Q2
$4.38M Sell
25,237
-873
-3% -$145K 0.3% 75
2024
Q1
$4.42M Buy
26,110
+328
+1% +$61.4K 0.31% 69
2023
Q4
$5.09M Sell
25,782
-737
-3% -$130K 0.38% 53
2023
Q3
$4.61M Sell
26,519
-940
-3% -$171K 0.38% 52
2023
Q2
$4.73M Sell
27,459
-360
-1% -$62.2K 0.36% 53
2023
Q1
$4.63M Sell
27,819
-1,503
-5% -$246K 0.36% 53
2022
Q4
$4.3M Sell
29,322
-13,375
-31% -$1.98M 0.34% 61
2022
Q3
$6.33M Sell
42,697
-667
-2% -$111K 0.53% 42
2022
Q2
$7.45M Sell
43,364
-7,138
-14% -$1.23M 0.56% 42
2022
Q1
$9.52M Sell
50,502
-5,435
-10% -$1.07M 0.61% 41
2021
Q4
$13.7M Sell
55,937
-529
-0.9% -$116K 0.84% 33
2021
Q3
$11M Sell
56,466
-9,102
-14% -$1.84M 0.7% 34
2021
Q2
$12.2M Sell
65,568
-2,186
-3% -$380K 0.78% 31
2021
Q1
$10.7M Sell
67,754
-5,909
-8% -$936K 0.79% 33
2020
Q4
$12.2M Sell
73,663
-1,471
-2% -$239K 0.91% 29
2020
Q3
$12.4M Sell
75,134
-3,557
-5% -$547K 1.06% 24
2020
Q2
$10.8M Sell
78,691
-1,065
-1% -$139K 0.99% 25
2020
Q1
$9.39M Sell
79,756
-4,164
-5% -$548K 1.03% 25
2019
Q4
$11.1M Sell
83,920
-530
-0.6% -$65.9K 1.09% 24
2019
Q3
$10.5M Buy
84,450
+208
+0.2% +$25.1K 1.11% 24
2019
Q2
$9.56M Buy
84,242
+3,107
+4% +$325K 1.01% 26
2019
Q1
$8.17M Sell
81,135
-2,275
-3% -$207K 0.94% 28
2018
Q4
$7.13M Sell
83,410
-57
-0.1% -$5.13K 0.94% 25
2018
Q3
$7.64M Sell
83,467
-1,233
-1% -$109K 0.89% 27
2018
Q2
$7.22M Buy
+84,700
New +$7.15M 0.91% 25

Other funds holding ZTS

Equitable Trust's ZTS Position: Q1 2026 in Review

Equitable Trust reduced its Zoetis (ZTS) stake by 27% in Q1 2026, selling an estimated $612K and leaving 13,236 shares worth $1.56M. The position accounts for 0.07% of the portfolio, ranked #177.

Equitable Trust first reported a position in ZTS in Q2 2018 and has held it in 32 quarters since. The position peaked at $13.7M in Q4 2021. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Equitable Trust held 13,236 shares of Zoetis worth $1.56M as of Q1 2026.
  • Equitable Trust sold 4,947 Zoetis shares in Q1 2026, an estimated $612K.
  • Zoetis made up 0.07% of Equitable Trust's portfolio in Q1 2026, its #177 holding.
  • Equitable Trust first reported a position in Zoetis in Q2 2018 and has held it in 32 quarters since.
  • Equitable Trust's Zoetis position peaked at $13.7M in Q4 2021.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.